Summary The prognostic value of preoperative serum concentrations of carcinoembryonic antigen (CEA), CA 242, tissue polypeptide antigen (TPA), specific tissue polypeptide antigen (TPS) and human chorionic gonadotrophin beta (hCG,B) in 251 patients with colorectal cancer (39 Dukes' A, 98 Dukes' B, 56 Dukes' C and 58 Dukes' D) was investigated. When using the cut-off levels recommended for diagnostic purposes, there was a significantly longer overall survival in patients with low tumour marker levels compared with patients with elevated serum levels for all the investigated markers. In Dukes' stage B, C and D CA 242 emerged as a significant predictor of survival, whereas TPA, TPS and hCG,B showed a value only in Dukes' D. Unfortunately, no marker provided prognostic information in Dukes' A. In multivariate analysis, entering the tumour markers as continuous variables, Dukes' stage was the strongest prognostic factor, followed by CA 242. TPS, hCG,B and localisation of the tumour were also independent prognostic factors, whereas age, gender, CEA and TPA were not.
Colorectal cancer is a common disease in western countries and although many patients have resectable primary disease, recurrence after surgery with curative intent is a common cause of death. Stage according to the Dukes' classification is still the strongest prognostic factor to which other prognostic factors should be compared (Jass et al., 1986; Deans et al., 1992) . The prognostic information provided by the Dukes' staging system is not available or reliable preoperatively and also post-operatively there is a need to predict outcome within each Dukes' stage.
The serum levels of various tumour markers are easily determined and they may provide prognostic information preoperatively. They may be of clinical value in selecting the patients at high risk during follow-up regardless of Dukes' stage.
Carcinoembryonic antigen (CEA), which is the most used serological tumour marker in colorectal cancer for diagnosis and follow-up has also been studied as a prognostic marker, but its value in predicting outcome still remains controversial (Dhar et al., 1972; Wanebo et al., 1978; Goslin et al., 1980; Steele et al., 1982; de Mello et al., 1983; Wolmark et al., 1984; Briimmendorf et al., 1985; Bogenschiitz et al., 1986; Moertel et al., 1986; Wiggers et al., 1988; Filella et al., 1992; Hohenberger et al., 1994; Slentz et al., 1994; Wang et al., 1994; Lindmark et al., 1995) .
CA 242 and tissue polypeptide antigen (TPA) have recently been shown to be prognostic factors in colorectal cancer (Lindmark et al., 1995) and TPA was shown to be a superior prognostic factor to CEA, CA 242 and specific tissue polypeptide antigen (TPS) (Stahle et al., 1988a; Lindmark et al., 1995 (0) or above (1) the cut-off level]. Covariates were selected in a stepwise fashion (backward to forward), with the use of the maximum likelihood ratio. The P-value of 0.05 was adopted as the limit for inclusion of a covariate. The correlation of the tumour markers was calculated by linear regression using the logarithms of the serum levels.
Results
Carcinoembryonic antigen (CEA) The median preoperative serum CEA level was below 5 ng ml-1 (range <5-9000 ng ml -) ( Table I) . Sensitivity of CEA within each Dukes' stage is shown in Table II . The median survival of the 144 patients with serum levels lower than 5 ng ml-' was 5.0 years and that of 107 patients with a higher value 1.8 years. The difference between the survival curves was highly significant, P>0.0001 [RR 2.4, CI (95%) 1.7-3.5, X2=23, Figure 1 ]. When the patients were stratified by Dukes' stage, CEA was no longer a significant predictor of survival in any of the subgroups.
CA 242
The median preoperative serum CA 242 level was 11 U ml-' (range <5-20 000 U ml-') ( Table I) preoperative CA 242 serum levels below (----) or above ( ) the recommended cut-off level of 20 U ml-l. The P-value between the survival curves was highly significant (P<0.0001). The median preoperative serum level was 90 U I`(range 17-13 600 U l-1) ( Human chorionic gonadotrophin beta (hCGJ3) The median preoperative serum level of hCGJ was 0.79 pmol 1`(range <0.5-160 pmol l-1) ( Table I) . Sensitivity of hCGP within each Dukes' stage is shown in Table II. There were 208 patients with serum levels below 2 pmol I' and their median survival was 7.9 years compared with 1.0 year for 43 patients with serum levels above this level. The difference between the survival curves was highly significant, P<0.0001 [RR 2.9, CI (95%) 2.0-4.4, X2=27, Figure 5 ]. In Dukes' D cancer the difference between the survival curves was significant (P=0.047). In other stages the difference was not significant, although the difference approached significance in Dukes' B cancer (P=0.064).
Comparison of the tumour markers When comparing the tumour markers pairwise by linear regression using the logarithms of the serum levels, TPA and TPS showed strong correlation (R = 0.80), whereas the correlation between the other tumour markers was lower (Table III) . In multivariate analysis, Dukes' stage emerged as the strongest prognostic factor. When the tumour markers were entered into the model dichotomised at the recommended cut-off level, Dukes' stage was followed by CA 242 (P<0.0001), TPS (P=0.0002), age (P=0.0066) and localisation of the tumour (P = 0.029). CEA, hCG,B, TPA and gender did not emerge as independent prognostic factors. When entering the logarithms of the serum tumour marker levels as Years of follow-up Figure 4 Life table for patients with colorectal cancer with preoperative TPS serum levels below t----) or above ( ) the recommended cut-off level of 80U1-. The P-value between the survival curves was highly significant (P<0.0001). table for patients with colorectal cancer with preoperative hCGB,B serum levels below (----) or above ( ) the recommended cut-off level of 2 p moll-1. The P-value between the survival curves was highly significant (P<0.0001). All the investigated tumour markers provided prognostic information. An elevated serum level of any of the investigated tumour markers was strongly related to disseminated disease and poor survival. CA 242 was the only marker that provided prognostic information within Dukes' B and C colorectal cancer. In Dukes' D colorectal cancer not only CA 242 but also TPA, TPS and hCGfl showed a prognostic value. In contrast to many previous reports, CEA did not provide significant prognostic information in addition to stage of disease (Wanebo et al., 1978 : Wolmark et al.. 1984 : Brummendorf et al., 1985 Slentz et al., 1994; Wang 1994 : Lindmark et al., 1995 . In multivariate analysis CA 242, TPS and hCGJ were independent prognostic factors, when entering the serum tumour marker levels as continuous values. When entering the serum tumour marker levels as normal or elevated (dichotomised) in the model, hCGf dropped out. In a recent report CA 242 was, as in our study, shown to be a prognostic factor (Lindmark et al., 1995) . However, in that report TPA and CEA were found to be superior to CA 242, and in that respect the results differed markedly from our results. In an earlier study by the same group, TPA was found to be a superior prognostic factor to CEA and CA 50 in rectal cancer (StAhle et al.. 1988b) .
Previously., CA 242 has been reported to be a valuable additional diagnostic tool preoperatively and in the follow-up of patients with colorectal cancer (Kuusela et al., 1991 : Nilsson et al., 1992 Hall et al., 1994; Carpelan-Holmstr6m et al., 1995) . The results of this study further support previous findings, showing that the preoperative CA 242 serum level is an independent prognostic factor.
We conclude that the Dukes' stage is still the strongest prognostic factor in colorectal cancer and that CA 242 provides additional prognostic information within Dukes' stages B, C and D. TPS and hCGf were also shown to be independent prognostic factors but the difference in survival was significant only in advanced disease. The promising results on the prognostic value of CA 242 needs to be evaluated in prospective studies on colorectal cancer.
